Skip to main content
Top
Published in: Reactions Weekly 1/2017

01-04-2017 | Case report

Lithium

Hyperparathyroidism secondary to parathyroid adenoma: case report

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literature
go back to reference O'Shea R, et al. Hyperparathyroidism associated with long-term lithium therapy for the management of bipolar affective disease. Irish Journal of Medical Science 185 (Suppl. 10): S514, Nov 2016. Available from: URL: http://doi.org/10.1007/s11845-016-1499-2 [abstract] - Ireland O'Shea R, et al. Hyperparathyroidism associated with long-term lithium therapy for the management of bipolar affective disease. Irish Journal of Medical Science 185 (Suppl. 10): S514, Nov 2016. Available from: URL: http://​doi.​org/​10.​1007/​s11845-016-1499-2 [abstract] - Ireland
Metadata
Title
Lithium
Hyperparathyroidism secondary to parathyroid adenoma: case report
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-28261-8

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Carbamazepine

Case report

Epirubicin

Case report

Heparin